Estrogen receptor- in osteocytes is important for trabecular bone formation in male mice.
Academic Article
Overview
Research
Identity
Additional Document Info
Other
View All
Overview
abstract
The bone-sparing effect of estrogen in both males and females is primarily mediated via estrogen receptor- (ER), encoded by the Esr1 gene. ER in osteoclasts is crucial for the trabecular bone-sparing effect of estrogen in females, but it is dispensable for trabecular bone in male mice and for cortical bone in both genders. We hypothesized that ER in osteocytes is important for trabecular bone in male mice and for cortical bone in both males and females. Dmp1-Cre mice were crossed with ER(flox/flox) mice to generate mice lacking ER protein expression specifically in osteocytes (Dmp1-ER(-/-)). Male Dmp1-ER(-/-) mice displayed a substantial reduction in trabecular bone volume (-20%, P < 0.01) compared with controls. Dynamic histomorphometry revealed reduced bone formation rate (-45%, P < 0.01) but the number of osteoclasts per bone surface was unaffected in the male Dmp1-ER(-/-) mice. The male Dmp1-ER(-/-) mice had reduced expression of several osteoblast/osteocyte markers in bone, including Runx2, Sp7, and Dmp1 (P < 0.05). Gonadal intact Dmp1-ER(-/-) female mice had no significant reduction in trabecular bone volume but ovariectomized Dmp1-ER(-/-) female mice displayed an attenuated trabecular bone response to supraphysiological E2 treatment. Dmp1-ER(-/-) mice of both genders had unaffected cortical bone. In conclusion, ER in osteocytes regulates trabecular bone formation and thereby trabecular bone volume in male mice but it is dispensable for the trabecular bone in female mice and the cortical bone in both genders. We propose that the physiological trabecular bone-sparing effect of estrogen is mediated via ER in osteocytes in males, but via ER in osteoclasts in females.
